Clinical research on sarcoma

Current open trials in Cambridge

The table below lists the current open trials for sarcoma coordinated by the Cambridge Cancer Trials Centre (last updated January 2016).

Trial name Trial description Contact
EURAMOS 1 A randomized trial of the European and American Osteosarcoma study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy  
STS 2006 03 (NRSTS) EpSSG NRSTS 2005 - A protocol for localised non-rhabdomyosarcoma soft tissue sarcomas Dr Denise Williams
UK Gastrointestinal Stromal Tumour (GIST) Registry To set up a specific GIST registry, which will enable incidence, prevalence, recurrence, survival and mortality rates, as well as treatment practices, to be monitored, thereby enabling therapeutic intervention to be evaluated and ultimately optimised. Dr Ramesh Bulusu
Uterine LMS study A Phase III Randomised Trial of Gemcitabine plus Docetaxel followed by Doxorubicin versus observation for uterus-limited, high grade uterine leiomyosarcoma. Dr Helen Hatcher

If you would like further information about how to take part in any of the clinical trials listed here, please talk to your cancer specialist as patients usually need to be referred by their doctor.

Cambridge Cancer Trials Centre contact for sarcoma trials: Dr Helena Earl